Catherine Wood's ADPT Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 2.14 M shares of Adaptive Biotechnologies Corporation (ADPT) worth $34.74 M, representing 0.23% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 2.01 M shares. Largest reduction occurred in Q2 2025, reducing 3.72 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.03 M | Reduce 32.43% | 2.14 M | $16.24 |
| Q3 2025 | -850,849 | Reduce 21.18% | 3.17 M | $14.96 |
| Q2 2025 | -3.72 M | Reduce 48.06% | 4.02 M | $11.65 |
| Q1 2025 | -1.69 M | Reduce 17.95% | 7.73 M | $7.43 |
| Q4 2024 | -2.18 M | Reduce 18.77% | 9.42 M | $6.00 |
| Q3 2024 | +189,134 | Add 1.66% | 11.6 M | $5.12 |
| Q2 2024 | +850,704 | Add 8.05% | 11.41 M | $3.62 |
| Q1 2024 | -2.25 M | Reduce 17.53% | 10.56 M | $3.21 |
| Q4 2023 | +1.3 M | Add 11.27% | 12.81 M | $4.90 |
| Q3 2023 | +1.06 M | Add 10.10% | 11.51 M | $5.45 |
| Q2 2023 | +1.25 M | Add 13.56% | 10.45 M | $6.71 |
| Q1 2023 | +3,880 | Add 0.04% | 9.21 M | $8.83 |
| Q4 2022 | -135,374 | Reduce 1.45% | 9.2 M | $7.64 |
| Q3 2022 | +563,601 | Add 6.42% | 9.34 M | $7.12 |
| Q2 2022 | +1.06 M | Add 13.79% | 8.77 M | $7.82 |
| Q1 2022 | +2.01 M | Add 35.31% | 7.71 M | $13.88 |
| Q4 2021 | +841,447 | Add 17.33% | 5.7 M | $28.06 |
| Q3 2021 | +489,444 | Add 11.21% | 4.86 M | $33.99 |
| Q2 2021 | +893,067 | Add 25.71% | 4.37 M | $40.86 |
| Q1 2021 | +1.93 M | Add 124.75% | 3.47 M | $40.26 |
| Q4 2020 | +660,981 | Add 74.71% | 1.55 M | $59.13 |
| Q3 2020 | +575,584 | Add 186.19% | 884,722 | $48.63 |
| Q2 2020 | +309,138 | New Buy | 309,138 | $48.38 |
Catherine Wood's Adaptive Biotechnologies Corporation Investment FAQs
Catherine Wood first purchased Adaptive Biotechnologies Corporation (ADPT) in Q2 2020, acquiring 309,138 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Adaptive Biotechnologies Corporation (ADPT) for 23 quarters since Q2 2020.
Catherine Wood's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q1 2022, adding 7,709,666 shares worth $107.01 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 2,138,960 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $34.74 M.
As of the Q4 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.23% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 12,806,513 shares, as reported at the end of Q4 2023.